Position in AMGN
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$5,722,582
+$353,000 QoQ
Shares Held
15,803
+3.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
#772
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Resonant Capital Advisors, LLC holds $36,919,957 across 13 Drug Manufacturers - General names. AMGN ranks #2 (15.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,392 | $7,666,757 | |
| 2 | AMGN |
Amgen Inc
This page
|
15,803 | $5,722,582 | |
| 3 | JNJ |
Johnson & Johnson
|
19,135 | $4,859,715 | |
| 4 | ABBV |
AbbVie Inc.
|
16,399 | $4,126,644 | |
| 5 | MRK |
Merck & Co., Inc.
|
31,697 | $4,073,064 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
30,095 | $3,802,202 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
49,118 | $2,830,179 | |
| 8 | PFE |
Pfizer Inc
|
52,773 | $1,270,773 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,722,582 | 15,803 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $5,369,582 | 15,261 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $4,858,916 | 14,845 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $3,807,724 | 13,493 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $3,675,520 | 13,164 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $4,003,729 | 12,851 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $3,125,855 | 11,993 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $3,938,050 | 12,222 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $3,790,955 | 12,133 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $3,311,190 | 11,646 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $3,333,255 | 11,573 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $3,398,738 | 12,646 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $2,745,277 | 12,365 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $3,067,565 | 12,689 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $3,280,898 | 12,492 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $2,793,382 | 12,393 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $2,996,482 | 12,316 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $2,933,034 | 12,129 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $2,536,536 | 11,275 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $2,009,967 | 9,452 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $1,950,731 | 8,003 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $1,936,737 | 7,784 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $1,600,243 | 6,960 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $1,604,512 | 6,313 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $1,516,579 | 6,430 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,766,386 | 8,713 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||